Previous 10 | Next 10 |
IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogenic Pump for its Next-Generation Cryoablation Systems PR Newswire Innovating as a global leader in cryoablation technologies, with 29 patents issued and allowed Cryogenic pump enables multip...
IceCure Medical ( NASDAQ: ICCM ) said on Tuesday it was publicly offering 8.79M shares priced at-the-market to the public of $1.65 per share. ( ICCM ) has risen ~9% before the bell. The gross proceeds, which is about $14.5M, will be used to fund the development of...
IceCure Medical Ltd. Announces Closing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules PR Newswire CAESAREA, Israel , Dec. 23, 2022 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer o...
IceCure Medical Ltd. Announces Pricing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules PR Newswire CAESAREA, Israel , Dec. 21, 2022 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer o...
Top Tips to Use for Finding Penny Stocks to Buy Identifying penny stocks with high potential requires a combination of research, due diligence, and risk management. The key is to look for penny stocks that have strong fundamentals, are trading at a low price, and have the potential to gen...
IceCure Medical ( NASDAQ: ICCM ) on Tuesday announced the commencement of a proposed public offering of its ordinary shares. All of the securities to be sold in the offering are to be offered by IceCure. A.G.P./Alliance Global Partners is acting as lead placement agent for the...
IceCure Medical Ltd. Announces Proposed Public Offering PR Newswire CAESAREA, Israel , Dec. 20, 2022 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the ProSen...
IceCure Medical ( NASDAQ: ICCM ) has risen four-folds after the company announced interim results from a study for its minimally-invasive cryoablation technology, the ProSense System that destroys tumors by freezing, to treat patients with small renal masses who cannot b...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: iQoncept / Shutterstock Sintx Technologies (NASDAQ: SINT ) stock is in the news Tuesday as the company enacted a reverse stock split when markets opened this morning. That reverse stock split has Sintx T...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Verona Pharma (NASDAQ: VRNA ) stock is rising higher on Tuesday after the company released results from a Phase 3 clinical trial . The big news here is the company’s Phase 3 ENHANCE-1 ...
News, Short Squeeze, Breakout and More Instantly...
99.74% Recurrence Free Rate for Women with Breast Cancer Treated with IceCure's ProSense® Cryoablation System: Key Findings Delivered at 32nd Annual Meeting of the Japanese Breast Cancer Society PR Newswire Demand for minimally invasive breast cancer treatment was ove...
European Study Provides More Evidence Supporting IceCure's ProSense® is Safe & Effective Cryoablation Treatment for Metastatic and Recurrent Breast Cancer European Study Provides More Evidence Supporting IceCure's ProSense® is Safe & Effective Cryoablation Treatment fo...
U.S. Food and Drug Administration Grants Regulatory Clearance to IceCure for Next-Gen XSense™ Cryoablation System with CryoProbes PR Newswire CAESAREA, Israel , July 1, 2024 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medic...